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ABSTRACT
Introduction Despite early adoption of the WHO
guidelines to deliver lifelong antiretroviral (ARV) regimen
to pregnant women on HIV diagnosis, the HIV prevention
of mother to child transmission programme in Papua New
Guinea remains suboptimal. An unacceptable number of
babies are infected with HIV and mothers not retained in
treatment. This study aimed to describe the characteristics
of this programme and to investigate the factors
associated with programme performance outcomes.
Methods We conducted a retrospective analysis of clinical
records of HIV-positive pregnant women at two hospitals
providing prevention of mother to child transmission
services. All women enrolled in the prevention of mother
to child transmission programme during the study period
(June 2012–June 2015) were eligible for inclusion. Using
logistic regression, we examined the factors associated
with maternal loss to follow-up (LTFU) before birth and
before infant registration in a paediatric ARV programme.
Results 763 of women had records eligible for inclusion.
Demographic and clinical differences existed between
women at the two sites. Almost half (45.1%) of the
women knew their HIV-positive status prior to the current
pregnancy. Multivariate analysis showed that women
more likely to be LTFU by the time of birth were younger
(adjusted OR (AOR)=2.92, 95% CI 1.16 to 7.63), were
newly diagnosed with HIV in the current/most recent
pregnancy (AOR=3.50, 95% CI 1.62 to 7.59) and were in
an HIV serodiscordant relationship (AOR=2.94, 95% CI
1.11 to 7.84). Factors associated with maternal LTFU
before infant registration included being primipara at
the time of enrolment (AOR=3.13, 95% CI 1.44 to 6.80)
and being newly diagnosed in that current/most recent
pregnancy (AOR=2.49, 95% CI 1.31 to 4.73). 6.6% (50 of
763) of exposed infants had a positive HIV DNA test.
Conclusions Our study highlighted predictors of LTFU
among women. Understanding these correlates at different
stages of the programme offers important insights for
targets and timing of greater support for retention in care.

Strengths and limitations of this study
►► This study used real-world data from the national

HIV prevention of mother to child transmission programme in Papua New Guinea (PNG), providing data
that reflect programme delivery in a routine setting.
►► The study included over 700 clinical records, comprising the largest and most systematic evaluation
of prevention of mother to child transmission programmes in PNG.
►► The retrospective nature of the study made it reliant
on the quality of data that had been collected, which
in many cases were incomplete.
►► Missing data limited the choice of data analysis
approaches.
►► Despite data limitations, this study provides important insights into the prevention of mother to child
transmission programmes in PNG, and findings
can be used to inform the development of effective
interventions.

INTRODUCTION
Maternal early initiation and adherence to
antiretroviral therapy (ART) during pregnancy and breast feeding and prophylactic
administration of antiretrovirals (ARV) to
infants exposed to HIV can reduce the risk
of transmission to newborns from 30%–45%
to less than 5%.1–3 Through a combination of
advancements in medicines, political commitment, multilateral funding and a dedicated

Kelly-Hanku A, et al. BMJ Open 2020;10:e038311. doi:10.1136/bmjopen-2020-038311

1

BMJ Open: first published as 10.1136/bmjopen-2020-038311 on 12 December 2020. Downloaded from http://bmjopen.bmj.com/ on May 5, 2021 by guest. Protected by copyright.

Loss to follow up of pregnant women
with HIV and infant HIV outcomes in
the prevention of maternal to child
transmission of HIV programme in two
high-burden provinces in Papua New
Guinea: a retrospective clinical audit

Open access

2

child transmission programme characteristics and investigate factors associated with programme performance
outcomes.

METHODS
Study settings
The two sites were selected as they were both in high-
burden HIV provinces, were the longest running sites
for prevention of mother to child transmission in the
country, and were well supported through donor funding
and non-governmental organisations, such as the Clinton
Health Access Initiative. Port Moresby is the national
capital city, on the southern coast of the country, and is a
melting pot of people from across the country. It is one of
only three cities in the country. Goroka is a town and the
provincial capital of the Eastern Highlands Province, in
the lower highlands region of the country. The geographical, sociocultural and economic contexts of these two
sites are diverse. Unlike Port Moresby, Goroka is much
smaller and people access the town from across the province, travelling by foot and road. Travel between these
two sites is only possible by air. HIV testing is available at
numerous ANC clinics in each province; however, there
is only one prevention of mother to child transmission
clinic in each province.
The implementation model for the prevention of
mother to child transmission programme differed
between the two sites. In Port Moresby, prevention of
mother to child transmission services were integrated in
antenatal, delivery and postnatal care services for the first
6 weeks. After the 6-week postnatal period, HIV-exposed
infants were referred for enrolment in the paediatric
HIV clinic for ongoing HIV prophylaxis, confirmatory
HIV testing and treatment as required, while mothers
were referred to the adult ART outpatient clinic. The
adult and paediatric HIV clinics were not co-located and
operated on different days, and clinical records were not
linked manually or electronically. In Goroka, prevention
of mother to child transmission services were integrated
in antenatal, delivery and postnatal care, and the mother-
infant pair is cared for by the same clinical team until the
confirmatory HIV test for the infant was conducted at 18
months. Despite its co-location infants were still enrolled
in the paediatric HIV clinic at 6 weeks. At 18 months after
birth, the mother was transferred (back) to the adult
ART clinic, while the HIV-infected infant/s remained in
the clinic for ongoing clinical care and management. All
healthcare was provided by staff who were employed as
government healthcare workers or were supported and
funded by the Clinton Health Access Initiative, funded by
the Australian government.
Study participants and procedures
The clinical audit used a ‘capture all’ approach, documenting all women with HIV enrolled in the prevention
of mother to child transmission programme for the 3-year
time period spanning June 2012 (when Option B+ was
Kelly-Hanku A, et al. BMJ Open 2020;10:e038311. doi:10.1136/bmjopen-2020-038311
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health workforce, many countries have now eliminated
mother to child transmission of HIV.4 5 Many settings have
made significant progress in the implementation of the
WHO-
recommended Option B+ regimen, whereby all
pregnant and breastfeeding women living with HIV are
offered lifelong ART on diagnosis.6 However, many countries which have adopted Option B+, including Papua
New Guinea (PNG), continue to struggle in providing
effective prevention of mother to child transmission
programmes and in retaining mothers and infants in lifelong care and treatment.7–9
Supporting maternal adherence to ART and retaining
mothers and infants in these treatment programmes
are essential components in preventing mother to
child transmission of HIV. Factors contributing to
lower adherence and greater loss to follow-up (LTFU)
from prevention of mother to child transmission
programmes include concerns with lifelong treatment,
inadequate counselling, lack of male partner involvement and support, fear of disclosure, knowing someone
who has had a negative experience, and distance to the
health facility.10–15 Conversely, good-quality HIV post-
test counselling, support from partners and family,
belief in ART efficacy and being aware of the improved
survival of other people have been reported as facilitators to initiation of ART, adherence and reduced
LTFU from prevention of mother to child transmission
programmes.11 12 14–16
PNG is an independent Western Pacific Island nation
of more than eight million people living a largely subsistence livelihood in geographically challenging terrain.
Roads poorly connect major centres, and where roads
exist landslides, tribal fighting and lawlessness often
restrict reliable and safe travel routes. The overall adult
HIV prevalence (15–49 years) is 0.8%,17 higher in urban
areas, and substantially greater among key populations
of female sex workers, men who have sex with men and
transgender women.18–20 Consistent with WHO recommendations, PNG’s HIV treatment guidelines follow
a test-
and-
treat model, including lifelong treatment
for pregnant and breastfeeding women.21 Despite the
progressive approach, it is estimated that only half (55%;
26 400 of 48 000) of people living with HIV were receiving
ART in 2017, and of the estimated 1700 pregnant women
living with HIV only 41% received ART.22 The need for
improvements in the prevention of mother to child
transmission programmes is further highlighted by the
fact that the number of babies born with HIV doubled
between 2017 and 2018.23 What remains unknown is
where and for which subpopulations the mother to
child transmission programme is failing. Answers from
national programmes could offer insight on where to
target interventions to ensure women are not LTFU
and to refocus and galvanise efforts to reduce neonatal
infections to achieve the goal of eliminating mother to
child transmission. We conducted a retrospective clinical
audit at two antenatal clinics (ANC) in Goroka and Port
Moresby in PNG to describe prevention of mother to
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Study measures and analysis
At enrolment into the prevention of mother to child
transmission programme, sociodemographic, obstetric
and HIV-related characteristics were recorded and laboratory assessments conducted. In our analysis we only
included the first pregnancy when assessing maternal
characteristics and outcomes. However, for infant characteristics and outcomes, all live births were included.
LTFU was measured and defined at two timepoints. First,
pregnant women enrolled in the prevention of mother to
child transmission programme were categorised as ‘lost
to follow-up before delivery’ if they did not return to the
health facility for delivery, and could include scheduled
antenatal prevention of mother to child transmission
visits. Second, pregnant enrolled women in the prevention of mother to child transmission programme were
defined as ‘lost to follow-up before infant registration’
if they did not register the newborn child at the respective clinics for prevention of mother to child transmission services and were lost from the programme either
during antenatal, peripartum or early postnatal services.
Although the study sponsor originally sought to have the
audit measure maternal LTFU at 2 years after lifetime
ART initiation in the prevention of mother to child transmission programme (Option B+), this was not possible.
In PNG, paper-based adult ART records were used and
there was no system that linked women in prevention
from mother to child transmission programmes to adult
Kelly-Hanku A, et al. BMJ Open 2020;10:e038311. doi:10.1136/bmjopen-2020-038311

ART service records. At the time the audit was undertaken, only two ART sites in Port Moresby were using an
electronic database, which was manually updated into
a national database by staff at the National Department
of Health every few months. Enrolment of a child into
paediatric HIV programmes shows ongoing engagement
in HIV care. The fact that so many women did not enrol
their children in these clinics shows disengagement. Like
prevention of mother to child transmission programmes,
there is only one paediatric HIV clinic in each province.
Descriptive analyses were conducted to describe the
women enrolled in the prevention of mother to child
transmission programmes at the sites and the HIV
outcomes of their infants. χ2 tests, two-sample t-tests and
Wilcoxon rank-
sum tests were performed to examine
differences in sociodemographic and other behavioural
characteristics of women and infants in the sites. Multivariate logistic regression analysis was undertaken to investigate factors associated with maternal LTFU before birth
and the mean time before the infant was registered in
a paediatric ART programme. Based on findings from
previous research24 and data available from this study, we
selected variables that might influence the outcome of
interest (maternal LTFU) to be included in the predictive models. For the analysis of factors associated with
maternal LTFU before birth, we used Firth’s logistic
regression25 26 to account for bias due to rare event data,
which are known to produce substantial bias estimates
with conventional logistic regression.27 Assumption of
rare event data was made based on few outcome events
per variable (EPV) guideline with at least five EPV in
models used for confounding adjustment.28 Infant HIV
testing and results were quantified and described.
Ethical considerations
This was a retrospective cohort study and women were
no longer attending the ANC. Consent from the participating hospitals was granted to access clinical records on
the condition that no identifiable information, including
names, was recorded on the clinical research forms.
Patient and public involvement
We did not invite patient and public involvement in the
design of the study due to the nature of the study, being
a retrospective clinical audit commissioned by UNICEF.
All study results were disseminated to stakeholders at the
conclusion of the study.

RESULTS
Description of sample set
A total of 849 cases were identified and registered into the
prevention of mother to child transmission programme
across the two sites (figures 1 and 2). Eight women and
their records were excluded as they described women who
were not pregnant (n=4), not HIV-infected (n=3) or had
been diagnosed through a sick child (n=1). Of the 841
remaining eligible pregnancies, 39 (4.6%) had missing
3
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formally adopted in PNG) until June 2015. Data sources
included paper-based antenatal records of HIV-positive
women and their infants’ medical records at either the
same prevention of mother to child transmission clinic
(Goroka) or the paediatric HIV clinic elsewhere in the
hospital (Port Moresby).
For all available records, two research midwives manually extracted data related to patient demographics, pregnancy care, HIV and other sexually transmitted infection
testing, prevention of mother to child transmission enrolment, ART initiation and clinic appointments, and these
were recorded on preprinted study clinical research
forms. Infants’ HIV DNA test results were obtained from
infant records. Infant records in Goroka were physically
co-located with the mothers. In Port Moresby, mother-
infant pairs were linked manually by extracting the name
of the mother, the birth date of the infant on her ANC
record, and if recorded the sex of the newborn. Staff at
the paediatric HIV clinic then identified infant records to
link the mother-infant pairs.
Research midwives cross-
checked each other’s
completed data forms to ensure all forms were completed
as accurately as possible. After reviewing each form for
validity and completeness, de-identified data were double-
entered into a purposely developed study database and
stored on a password-protected computer at the Papua
New Guinea Institute of Medical Research. All electronic
data were merged into a single study database and analysed using STATA V.13.1.

Open access

Sociodemographic characteristics of enrolled women
One-third of the analysed records were from women registered at the Goroka prevention of mother to child transmission site and the other two-thirds from Port Moresby.
The mean age of participants was 25 years at both sites.
A greater proportion of women in Port Moresby were
married (77.3% compared with 51.4%, p<0.001), had
received any formal education (92.2% compared with
72.4%, p<0.001) and were employed in the formal sector
(21.1% compared with 1.7%, p<0.001) than women in
Goroka (table 1).
Figure 1 Flow diagram of eligible pregnant women. ANC,
antenatal clinic.

ANC records, 11 records (1.3%) described women who
had twins, and 28 women (3.3%) had two pregnancies in
the study period and were therefore enrolled twice in the
prevention of mother to child transmission programme in
the period under investigation. The final analysed sample
therefore described 763 eligible HIV-positive pregnant
women (figure 1), which resulted in 763 live births and
30 stillbirths (figure 2). Not all records were complete.
PNG uses paper-
based records systems for prevention

Figure 2 Flow diagram of eligible births. LTFU, loss to
follow-up; PICT,Provider initiated counseling and testing.

4

HIV and ART characteristics of enrolled women
Table 1 also details the HIV and ART characteristics of
the population. Just over half (54.9%) of the cohort were
newly diagnosed with HIV in their current pregnancy, with
this proportion being greater in Port Moresby (57.9%)
compared with Goroka (49.0%, p=0.020; table 2). In
Goroka, women who already knew they were HIV-positive
enrolled in the prevention of mother to child transmission programme earlier than those in Port Moresby
(mean gestational weeks at enrolment 22.5 for Goroka
and 26.1 for Port Moresby, p<0.001); however, timing of
enrolment was not statistically different across the two
sites for newly diagnosed women (table 2).
The median CD4 T cell count at enrolment into the
programme was 327 cells/µL in Goroka, compared with
273 cells/µL in Port Moresby (p=0.005). More than 10%
of all women were positive for antibodies to hepatitis
B virus (13.7% in Goroka and 12.3% in Port Moresby,
p=0.61).
Most (99.7%) of the women at both sites were receiving
ART (table 2). Among those who already knew they
positive, most (91.3%) were taking ongoing
were HIV-
treatment, with 8.7% recommencing treatment during
the current pregnancy. While 100% of newly diagnosed
women in Port Moresby were receiving ART, this was
significantly lower among women in Goroka (92.4%,
p<0.001).
Among women who were newly diagnosed, ART initiation was slower in Goroka with a median time between
diagnosis and ART initiation of 14 days compared with
5 days in Port Moresby (p<0.001), and only 34.3% of
women initiated treatment on the day of enrolment in the
prevention of mother to child transmission programme in
Goroka compared with 60.7% in Port Moresby (p<0.001).
These delays translated to a higher proportion of newly
diagnosed women receiving ART for less than 2 weeks
before birth in Goroka (11.9%) compared with Port
Moresby (6.1%, p=0.002).
Kelly-Hanku A, et al. BMJ Open 2020;10:e038311. doi:10.1136/bmjopen-2020-038311
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of mother to child transmission and paediatric HIV
programmes that are not linked by a unique identification code or any other identifier. The challenges associated with linking mother-infant pairs resulted in some
data not being available. The changing denominators in
the table indicate where data were missing.
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All women (n=763)
% (n/N)

Goroka (n=256)
% (n/N)

Port Moresby
(n=507)
% (n/N)

Mean age (SD), n=761
Marital status

25.4 (5.05)

25.7 (5.4)

25.3 (4.9)

 Married

68.5 (518/756)

51.4 (131/255)

77.3 (387/501)

 Married-polygamist

21.6 (163/756)

40.0 (102/255)

12.2 (61/501)

 Single/no partner/boyfriend only

8.1 (61/756)

6.3 (16/255)

9.0 (45/501)

 Widow

1.9 (14/756)

2.4 (6/255)

1.6 (8/501)

Education
14.7 (107/730)

27.6 (70/254)

7.8 (34/476)

 Primary education only

41.0 (299/730)

42.5 (108/254)

40.1 (191/476)

 Secondary education only

36.6 (267/730)

24.8 (63/254)

42.9 (204/476)

 College/technical/vocational

6.4 (47/730)

4.7 (12/254)

7.4 (25/476)

 University

1.4 (10/730)

0.4 (1/254)

1.9 (9/476)

 Informal sector

29.3 (204/696)

38.5 (89/231)

24.7 (115/465)

 Formal employment

14.7 (102/696)

1.7 (4/231)

21.1 (98/465)

 No paid work

54.6 (380/696)

58.9 (136/231)

52.5 (244/465)

1.4 (10/696)

0.9 (2/231)

1.7 (8/465)

55.8 (415/744)

93.8 (240/256)

35.9 (175/488)

5.1 (38/744)

4.3 (11/256)

5.5 (27/488)

36.6 (272/744)

1.2 (3/256)

55.1 (269/488)

2.6 (19/744)

0.8 (2/256)

3.5 (17/488)

 Nullipara

33.0 (250/758)

32.4 (83/256)

33.3 (167/502)

 Primipara

30.5 (231/758)

26.9 (69/256)

32.3 (162/502)

 Multipara

36.5 (277/758)

40.6 (104/256)

34.5 (173/502)

Employment

<0.001

Region of origin
 Highlands Region
 Momase Region
 Southern Region, including NCD
 New Guinea Islands Region

<0.001

Parity

0.185

Relationship HIV status

0.105

 Concordant HIV positive

36.5 (248/679)

41.4 (106/256)

33.6 (142/423)

 Discordant HIV status

17.1 (116/679)

14.8 (38/256)

18.4 (78/423)

 Unknown status/no partner

46.4 (315/679)

43.8 (112/256)

48.0 (203/423)

86.8 (524/604)

95.3 (221/232)

81.5 (330/372)

HIV status disclosure
 Yes

<0.001

Site of HIV testing

<0.001

 ANC

55.4 (405/731)

49.4 (122/247)

58.5 (283/484)

 HIV/SH clinic/VCT centre

28.3 (207/731)

36.4 (90/247)

24.2 (117/484)

 Subdistrict health/aid post

2.9 (21/731)

8.5 (21/247)

–

 Other area of hospital

1.1 (8/731)

2.4 (6/247)

0.04 (2/484)

 Private health clinic

0.6 (4/731)

 Other

0.33
<0.001

<0.001

 No formal education

 Student

P value

11.8 (86/731)

–

0.8 (4/484)
3.2 (8/247)

16.1 (78/484)

HIV status at ANC visit

0.02

 Known positive

45.1 (343/761)

51.0 (130/255)

42.1 (213/506)

 Newly diagnosed
CD4+ count at enrolment, median (IQR)

54.9 (418/761)

49.0 (125/255)

57.9 (293/506)
Continued
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Table 1 Sociodemographic, obstetric and HIV-related characteristics of 763 eligible women attending services in PNG
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Port Moresby
(n=507)
% (n/N)

All women (n=763)
% (n/N)

Goroka (n=256)
% (n/N)

 All women

290.5 (193–409),
n=650

327 (197–468), n=226 273 (190–384), n=424

0.005

 Known HIV-positive women

349 (235–477), n=288 364 (234–504), n=123 341 (236–451), n=165

0.219

 Newly diagnosed women

252.5 (176–360),
n=362

279 (169–419), n=103 249 (179–341), n=259

0.154

 All women (n=734)

26.1 (6.9)

25.2 (7.5)

26.6 (6.6)

0.01

 Known HIV-positive (n=332)

24.7 (7.2)

22.5 (6.9)

26.1 (7.0)

<0.001

 Newly diagnosed (n=402)

27.3 (6.6)

28.0 (7.1)

26.9 (6.3)

0.14

12.8 (77/602)

13.7 (30/219)

12.3 (47/383)

0.61

5.2 (23/441)

7.8 (17/218)

2.7 (6/223)

0.02

P value

Gestational age at enrolment, mean weeks
(SD)

Hepatitis B status
 Positive
Syphilis status
 Positive

ANC, antenatal clinic; NCD, National Capital District; PNG, Papua New Guinea; SH, sexual health clinic; VCT, voluntary counselling and
testing centre.

Infant follow-up and HIV test outcomes
There were a total of 763 live births from enrolled women
(table 2). Almost 1 in 10 births in Goroka (9.8%) were
non-
facility births, defined as births outside a health
facility, compared with 3.0% in Port Moresby (table 2).
Almost all newborns (97%) in Port Moresby received ARV
prophylaxis within 72 hours of birth, compared with only
two-thirds of newborns in Goroka (67.5%). While there
was no difference in the proportion of infants who had
ever registered in a paediatric HIV programme, the rates
of paediatric LTFU were much greater in Port Moresby
(45.7%) compared with Goroka (23.2%, p<0.001). One
in five infants (21.6%) were either not tested or had
HIV DNA testing data missing, and 6.6% of tested babies
returned a positive DNA test for HIV. Of these, only three-
quarters were started on ART in the study period.
Maternal follow-up and factors associated with being LTFU
Of the 77 women (77 of 755, 10.2%) who were LTFU
before they gave birth, we had sufficient programmatic
data from 49 women (63.6%) for the multivariate analysis
(table 3). Data were more complete for the Goroka site,
with 72% (46 of 64) of those LTFU having sufficient data
compared with only 23% (3 of 13) from Port Moresby
(data not shown).
Women aged 16–20 years were almost three times more
likely to be LTFU compared with those aged between 21
and 30 years when adjusted for other included variables
(adjusted OR (AOR)=2.92, 95% CI 1.16 to 7.36). Women
in an HIV serodiscordant relationship were three times
more likely to be LTFU (AOR=2.94, 95% CI 1.11 to 7.84)
compared with those in an HIV seroconcordant relationship, and women newly diagnosed during the current
6

pregnancy were more than three times more likely to be
LTFU before birth compared with women who already
knew they were HIV-positive (AOR=3.50, 95% CI 1.62 to
7.59).
Of the 113 women (113 of 757, 14.9%) who were LTFU
before infant registration, we had sufficient programmatic data from 61 women (54.0%) for the multivariate
analysis (table 4). Again, completeness of data was higher
for Goroka (64.5%) than for Port Moresby (50.0%).
Primipara women, as compared with nullipara women,
were significantly more likely to be LTFU before infant
registration (AOR=3.13, 95% CI 1.44 to 6.80), as were
women who were newly diagnosed in that current pregnancy (AOR=2.49, 95% CI 1.31 to 4.73).
DISCUSSION
In an attempt to quantify and explain maternal LTFU, this
clinical audit was the first to systematically scrutinise the
prevention of mother to child transmission programmes
in PNG, providing much needed evidence to guide future
programmatic efforts to improve outcomes for women
and their children. Across two high case load and well-
resourced sites, 1 in 10 of the women in this cohort were
LTFU before they gave birth (n=77, 10.2%) and a further
36 women were LTFU after birth but prior to registering
the infant in the paediatric HIV programme (n=113,
14.9%). More than 20% of HIV-exposed infants registered had no HIV testing data available, and of those who
had a DNA test at 18 months of age or older more than
6% tested positive for HIV.
More than half of the women in the cohort already knew
their positive HIV status, some having engaged in the
Kelly-Hanku A, et al. BMJ Open 2020;10:e038311. doi:10.1136/bmjopen-2020-038311
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Table 1 Continued
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All women
% (n/N)

Goroka
% (n/N)

Port Moresby
% (n/N)

Mother variables (n=763 eligible pregnant women; 256 from Goroka and 507 from Port Moresby)
Known positive women on ART

0.212

 Total

99.7 (323/324)

99.1 (112/113)

100.0 (211/211)

 Ongoing treatment

91.3 (294/322)

93.7 (104/111)

90.1 (190/211)

8.7 (28/322)

6.3 (7/111)

10.0 (21/211)

97.8 (399/408)

92.4 (109/118)

100.0 (290/290)

 Recommenced in pregnancy
Newly diagnosed women on ART
Timing of ART initiation for newly diagnosed women

91.6 (349/381)

85.2 (86/101)

93.9 (263/280)

 <2 weeks before delivery

7.6 (29/381)

11.9 (12/101)

6.1 (17/280)

 After delivery

0.8 (3/381)

3.0 (3/101)

0.0 (0/280)

7 days

14 days

(1–21, 0–532)

(1–29, 0–532)

(0–16, 0–161)

5 days

n=396

n=106

n=290

Timing of ART initiation relative to PMTCT enrolment for
newly diagnosed women
 Before enrolment

<0.001
0.002

 ≥2 weeks before delivery

Delay between diagnosis and ART initiation for newly
diagnosed women, median days (IQR, range)

P value

<0.001

<0.001
6.0 (24/392)

0.9 (1/108)

7.9 (23/290)

 On day of enrolment

53.5 (213/398)

34.3 (37/108)

60.7 (176/290)

 <1 week of enrolment

15.1 (60/398)

17.6 (19/108)

14.1 (41/290)

 >1 week of enrolment

25.4 (101/398)

Duration of care from enrolment to delivery, median days 86 days
(IQR)
(50–121)
n=718

47.2 (51/108)
94 days
(53–136)
n=230

17.2 (50/290)
81 days
(49–114)
n=488

0.018

Duration of ART before delivery, median days (IQR)
 Newly diagnosed women

71 (36–103)

57 (26–85)

 

n=381

n=101

 Known positive women recommencing

108 (37–987)

167 (41–819)

 

n=49

n=15

 Known positive women on ART

887 (431–1636)

949 (500–1595)

 

n=261

n=92

75 (42–106)
104 (24–1126)
866 (379–1690)

<0.001
10.2 (77/755)

25.5 (64/251)

2.6 (13/504)

 No

88.7 (670/755)

71.3 (179/251)

97.4 (491/504)

1.1 (8/755)

3.2 (8/251)

0.0 (0/504)

3.4 (27/757)

6.4 (16/252)

2.6 (11/505)

 LTFU

14.9 (113/757)

12.3 (31/252)

16.2 (82/505)

 In follow-up

81.5 (617/757)

81.4 (205/252)

81.6 (412/505)

LTFU before infant registration

0.007

Delivery details
 Supervised delivery
 Unsupervised delivery

0.616

n=169

 Yes

 Infant death

0.914

n=34

LTFU before delivery

 Deceased

<0.001

n=280

<0.001
591/763 (77.5)

129/256 (50.4)

40/763 (5.2)

25/256 (9.8)

 Data not available
132/763 (17.3)
102/256 (39.8)
Infant variables (n=763 live births; 251 from Goroka and 512 from Port Moresby)

91.1 (462/507)
3.0 (15/507)
5.9 (30/507)
Continued
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Table 2 Time on antiretroviral therapy and on prevention of mother to child transmission programmes, and delivery and
follow-up characteristics of mothers and infants attending prevention of mother to child transmission programmes in PNG

Open access

All women
% (n/N)

Goroka
% (n/N)

Port Moresby
% (n/N)

Birth outcomes (n=793)
 Live births
 Stillbirths

P value
0.001

96.2 (763/793)

93.0 (251/270)

97.9 (512/523)

3.8 (30/793)

7.0 (19/270)

2.1 (11/523)

Proportion of infants who were given ARV prophylaxis
within 72 hours of birth

91.3 (564/618)

67.5 (81/120)

97.0 (483/498)

<0.001

Proportion of infants ever registered in a paediatric HIV
programme

87.2 (663/760)

92.3 (229/248)

84.8 (434/512)

0.16

Proportion of infants tested for HIV at least once during
follow-up
 Tested positive

0.081
6.6 (50/763)

6.0 (15/251)

6.8 (35/512)

 Tested negative

71.8 (548/763)

76.9 (193/251)

69.3 (355/512)

 Never tested/data not available/LTFU/infant death
Proportion of HIV-positive infants started on ART

21.6 (165/763)
74.0 (37/50)

17.1 (43/251)
80.0 (12/15)

23.8 (122/512)
71.4 (25/35)

0.527

ART, antiretroviral therapy; ARV, antiretroviral; LTFU, lost to follow-up; PMTCT, prevention of mother to child transmission; PNG, Papua New
Guinea.

prevention of mother to child transmission programme
for previous pregnancies. However, almost half the women
enrolled were newly diagnosed with HIV in the current
pregnancy. Consistent with findings from other settings,
women who were newly diagnosed were more likely to be
LTFU before they gave birth and/or before infant registration compared with women who already knew they
were living with HIV.9 29 This further emphasises the need
for strengthened support and counselling at the point
of entry into the prevention of mother to child transmission programme and when prescribing lifetime ART for
newly diagnosed women. Likewise, younger women were
more likely to be LTFU before delivery, indicating greater
support may need to be directed to this population. Differentiated HIV support is necessary; the potential role of
other women currently pregnant but who were already
living with HIV and on lifetime ART should not be overlooked. The implementation of improved programmes to
increase HIV testing rates among women of childbearing
age, including strengthening male involvement in ANC,
would also help to mitigate the chances of first becoming
aware of an HIV-positive status during pregnancy and
improve uptake of prevention of mother to child transmission services.30 It is not surprising that knowledge of
an HIV-positive status prior to pregnancy is associated
with increased adherence to ART.14 29 31 This audit also
demonstrated that women who were primiparous were
more likely to be LTFU before infant registration. While
the factors influencing this finding remain unknown, it
does speak to the need to target particular intervention
approaches at the populations that they are most needed.
Although prevention of mother to child transmission
programmes have received considerable research attention, recent systematic reviews on effective interventions
highlight that quality evidence is still lacking to guide
8

intervention design in improving uptake of ART and retention in programmes among mothers and their infants.32 33
Success along the HIV care cascade has been achieved
with comprehensive approaches. Using a comprehensive
integrated approach involving point-of-care CD4 testing,
integrated services and male community champions, a
study in Nigeria demonstrated that mothers with access
to comprehensively integrated system were more than
three times likely to initiate ART and were more likely
to be retained in care at 6 and 12 weeks post partum
compared with mothers receiving usual care.34 More
modest success in improving maternal enrolment in HIV
care, maternal ART initiation and infant testing rates is
achieved through less complex integration models, with
many of these models of HIV care not in and of themselves necessarily leading to better retention in HIV care
and prevention programmes at 6 weeks post partum.33 35
Therefore, co-location of maternal and child HIV care
and treatment programmes does not automatically lead
to better HIV care and treatment outcomes,36 as our analysis shows. In our audit, LTFU rates for mothers before
delivery were greater from the Goroka site which had
co-located adult ART and prevention of mother to child
transmission services. A multitude of factors previously
reported to negatively impact retention in programmes,
including long distances to the clinic,10 37 long wait times
and lower educational attainment,38 are all relevant to
women enrolled in Goroka and are all likely to contribute
to LTFU, and these factors should be assessed and intervention approaches designed to mitigate their impact.
Again, differentiated HIV care is important in prevention
of mother to child transmission programmes, not just
among newly diagnosed mothers but across the country,
as women’s sociocultural status is varied, in some respects
significantly. For example, levels of education differ
Kelly-Hanku A, et al. BMJ Open 2020;10:e038311. doi:10.1136/bmjopen-2020-038311
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Table 2 Continued

Open access

Frequency
n/N (%)

Crude OR (95% CI)

Adjusted OR (95% CI) P value

1.0

1.0

46/197 (23.4)

30.46 (8.52 to 109.0)

39.7 (11.7 to 134.8)

 16–20 years

19/82 (23.2)

3.80 (1.97 to 7.32)

2.92 (1.16 to 7.36)

 21–30 years

25/340 (7.4)

 31–48 years

5/78 (6.4)

Site
 Port Moresby
 Goroka

<0.001
3/303 (1.0)

Age group
1.0
0.86 (0.32 to 2.33)

0.023

1.0
0.90 (0.29 to 2.73)

0.855

Marital status
 Married

24/335 (7.2)

 Married-polygamist

22/125 (17.6)

2.77 (1.48 to 5.19)

0.69 (0.31 to 1.53)

0.360

3/40 (7.5)

1.05 (0.30 to 3.66)

0.62 (0.14 to 2.68)

0.523

 Single/widow/no partner/boyfriend only

1.0

1.0

Education
 No formal education

14/79 (17.7)

1.0

1.0

 Primary education

20/203 (9.9)

0.51 (0.24 to 1.07)

0.78 (0.33 to 1.84)

0.567

 Secondary or more

15/218 (6.9)

0.34 (0.16 to 0.76)

0.66 (0.26 to 1.69)

0.389

Employment

0.400

 Formal or informal sector

19/228 (8.3)

 No paid work or student

30/272 (11.0)

1.0
1.36 (0.74 to 2.50)

1.0
0.73 (0.34 to 1.53)

Parity at enrolment
 Nullipara

26/153 (17.0)

1.0

1.0

 Primipara

10/153 (6.5)

0.34 (0.16 to 0.74)

0.74 (0.28 to 1.95)

0.539

 Multipara

13/194 (6.7)

0.35 (0.17 to 0.72)

0.58 (0.21 to 1.62)

0.301

Relationship HIV status
 Concordant HIV positive

12/212 (5.7)

 Discordant HIV status

12/94 (12.8)

2.44 (1.04 to 5.70)

1.0

2.94 (1.11 to 7.84)

1.0
0.030

 Unknown or no partner

25/194 (12.9)

2.47 (1.19 to 5.09)

1.82 (0.77 to 4.34)

0.173

HIV status disclosure
 Yes

44/444 (9.9)

 No

5/56 (8.9)

0.89 (0.34 to 2.35)

1.57 (0.41 to 5.99)

0.505

12/273 (4.4)
37/227 (16.3)

1.0
4.24 (2.12 to 8.46)

1.0
3.50 (1.62 to 7.59)

0.001

1.0

1.0

HIV status at ANC visit
 Known positive
 Newly diagnosed
ANC, antenatal clinic.

greatly, as does the prevalence of polygamous unions
where there are multiple wives.
Many intervention approaches targeting individual
behaviour have demonstrated potential in achieving
better outcomes for mothers and infants. The use of
phone calls and SMS (short message service)-based interventions can lead to improved maternal attendance,
improved infant testing rates and improved retention
at 6 weeks.33 39 Phone-
based interventions have not
been trialled in PNG, and it is questionable whether
this approach would be acceptable considering the
remaining stigma of being HIV-
positive and the rates
Kelly-Hanku A, et al. BMJ Open 2020;10:e038311. doi:10.1136/bmjopen-2020-038311

of non-disclosure in the community. In addition to this,
the high turnover of mobile phones and numbers could
make using this system problematic.
Previous work in other low-income settings has demonstrated that conditional cash transfers had a positive
impact on maternal attendance and retention,40 and
home visits by community-
based health workers have
resulted in higher proportions of infants breast feeding
and attending clinics within the first week of their life.41 As
PNG moves forward to improve the prevention of mother
to child transmission programmes across the country, this
may well be an approach that should be piloted.
9
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Table 3 Factors associated with enrolled mothers being lost to follow-up before they delivered their infants (n=500)

Open access

Frequency
n/N (%)
Site
 Port Moresby

41/299 (13.7)

 Goroka

20/192 (10.4)

Crude OR (95% CI)
1.0
0.73 (0.41 to 1.29)

Adjusted OR (95% CI) P value
1.0
0.60 (0.30 to 1.18)

0.139

Age group
 16–20 years

15/81 (18.5)

1.0

1.0

 21–30 years

42/334 (12.6)

0.63 (0.33 to 1.21)

0.63 (0.29 to 1.38)

0.246

 31–48 years

4/76 (5.3)

0.24 (0.08 to 0.80)

0.32 (0.08 to 1.22)

0.095

Marital status
 Married

35/330 (10.6)

 Married-polygamist

19/120 (15.8)

1.59 (0.87 to 2.90)

1.67 (0.83 to 3.37)

0.150

7/41 (17.1)

1.74 (0.71 to 4.22)

1.87 (0.70 to 5.00)

0.212

 Single/widow/no partner/boyfriend only

1.0

1.0

Education
 No formal education

11/76 (14.5)

1.0

1.0

 Primary education

33/202 (16.3)

1.15 (0.55 to 2.42)

0.92 (0.41 to 2.08)

0.849

 Secondary or more

17/213 (8.0)

0.51 (0.23 to 1.16)

0.42 (0.17 to 1.02)

0.056

Employment
 Formal or informal sector

22/223 (9.9)

 No paid work or student

39/268 (14.6)

1.0
1.56 (0.89 to 2.72)

1.0
1.40 (0.76 to 2.57)

0.277

Parity at enrolment
 Nullipara

19/150 (12.7)

1.0

1.0

 Primipara

26/148 (17.6)

1.47 (0.77 to 2.80)

3.13 (1.44 to 6.80)

0.004

 Multipara

16/193 (8.3)

0.62 (0.31 to 1.26)

1.48 (0.61 to 3.57)

0.384

Relationship HIV status
 Concordant HIV positive

17/213 (8.0)

 Discordant HIV status

12/94 (12.8)

1.69 (0.77 to 3.70)

1.0

1.70 (0.74 to 3.91)

1.0
0.215

 Unknown or no partner

32/184 (17.4)

2.43 (1.29 to 4.57)

1.47 (0.69 to 3.16)

0.318

HIV status disclosure
 Yes

47/436 (10.8)

 No

14/55 (25.5)

2.83 (1.42 to 5.61)

1.64 (0.70 to 3.80)

0.252

21/269 (7.8)
40/222 (18.0)

1.0
2.60 (1.47 to 4.59)

1.0
2.49 (1.31 to 4.73)

0.005

1.0

1.0

Knowledge of HIV status
 Known positive
 Newly diagnosed

In this audit, LTFU before delivery was more likely
among women who were living in an HIV discordant
relationship, and addressing this factor is likely to involve
greater male involvement in HIV care for women of childbearing age. Globally, there has been a focus on increasing
male involvement in ANC, particularly in the context of
prevention of mother to child transmission programmes.
A number of diverse approaches have been used and
show promising outcomes. For example, involving men
can result in improved outcomes, including increased
HIV testing in men, improved HIV-free survival of infants,
increased HIV disclosure between partners and improved
maternal adherence to care.42 In PNG male involvement
remains limited and is constrained by many factors. These
10

include persistent cultural beliefs that issues of pregnancy and childbirth are for women only, long waiting
times at ANC clinics, and financial barriers, including
loss of daily wage (or equivalent in subsistence farming
and marketing) to attend ANC and the additional cost
for transport. In order to improve male involvement and
see if this approach would benefit women and children,
substantial work needs to go into addressing the deeply
engrained sociocultural and health service barriers.43
While the rates of LTFU found here are comparative
with other settings with similar resources,7 what is of
concern to the programme in PNG is how late women
are enrolling in their pregnancies and their advanced
HIV disease status, as evidenced by their low CD4 counts,
Kelly-Hanku A, et al. BMJ Open 2020;10:e038311. doi:10.1136/bmjopen-2020-038311
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Table 4 Factors associated with enrolled mothers being lost to follow-up before infant registration (n=491)
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Limitations
In retrospective studies using routine data there are often
data challenges, with missing data precluding the inclusion of some women who were LTFU in the multivariate
analysis. We were challenged by the paper-based system
for this reason as well as the use of non-standardised
forms, both of which resulted in incomplete and inconsistent recording of patients’ medical histories. Paper-based
systems and the requirement to manually identify and
link mother and infant records resulted in a significant
delay to data collection and therefore strategic information to inform practice and policy. A computerised
database that can link women in prevention of mother
to child programmes to their children in paediatric HIV
services and their records in adult HIV services would
be a significant advancement for monitoring individual
patient outcomes as well as national data on programme
performance. The retrospective analysis also precluded
us from gathering any further information from women
who were LTFU on what barriers to remaining in care
they experienced. These qualitative enquiries would
further inform programme strengthening.

CONCLUSIONS
There is an urgent need for PNG to invest in its prevention of mother to child transmission programmes. In its
current state, as we have shown, an unacceptably high
proportion of women and their infants are LTFU, with
other poor indicators including delays in ART initiation, number of stillbirths, delayed infant prophylaxis,
high transmission rates and suboptimal testing rates.
Women within the programme need to be more strongly
supported to prevent LTFU and improve outcomes. With
the current programme, the goal of the elimination of
prevention of mother to child transmission will remain
elusive and the health and well-being of women living
with HIV and their children suboptimal.
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particularly for newly diagnosed women. At the time
of this work and today in PNG, pregnant women with
HIV are not offered HIV viral load testing; they are not
a population eligible for such testing in the approved
testing algorithm, and therefore we cannot examine
what, if any, HIV viral load plays in LTFU. Further to this
is the recorded delays between diagnosis and treatment
initiation, resulting in less time on ART prior to birth to
sufficiently reduce the viral load and reduce the risk of
mother to child transmission. These delays are important
to highlight as they offer obvious targets for programme
improvement to reduce viral load. Yet the other issue is
real: pregnant women who initiate treatment the day that
they are diagnosed have been shown to be significantly
less adherent than newly diagnosed pregnant women
whose treatment is delayed.44
Essential to reducing and eliminating paediatric infections, the coverage of timely ARV prophylaxis for infants
exposed to HIV must be resolved. In the period of this
study, one-third (39 of 120, 32.5%) of infants in Goroka
were not administered ARV prophylaxis within 72 hours of
birth. This figure may, in part, be due to the high number
of non-
facility-
based births, where mothers may have
been unable or unwilling to present to the prevention of
mother to child transmission clinic with their newborns
within 72 hours of birth. Improving counselling around
the importance of this prophylaxis, decentralising ARV
prophylaxis to lower health centres where women give
birth, encouraging supervised and facility-based births,
and providing the necessary financial and logistic means
to do so are interventions that warrant investigation.
Not only was the known HIV positivity rate among
infants exposed to HIV greater than it should be with
an effective prevention of mother to child transmission
programme, HIV DNA testing rates were also suboptimal, with more than 20% of infants having no evidence
of an HIV DNA test. These figures do not speak to effective programme implementation and provide evidence
of high LTFU and failure of the health system to reach
HIV-exposed infants with prevention of mother to child
transmission services. These key infant measures highlight the real and urgent need for programmes to reduce
infant LTFU to be adequately resourced and processes
facilitating early infant diagnosis to be strengthened as a
matter of urgency. Since this audit, no new programmes
or resources have been put towards the national prevention of mother to child transmission programme, so these
issues are likely to remain ever present, as highlighted
and reinforced at the PNG HIV summit that called for
a revitalisation amid expansion of the prevention of
mother to child transmission programme to reduce
transmission.45 Noting that, in 2017, 150 children were
diagnosed with HIV, a figure that doubled to 300 in 2018,
the report notes that ‘new-born children in PNG are
at dangerously increased risk of acquiring HIV’. Thus,
although this audit reflects years prior to this statement,
the report shows that the findings and issues raised by
the audit are current.
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